Fresh winter M&A deals reshape the pet industry
A new round of M&A is moving through the pet industry this winter, with activity touching premium nutrition, veterinary distribution, and digital pet care services. The recent headline deals include AlphaPet Ventures’ acquisition of Belgian pet food brand Cpro Food on March 27, 2026, and the February 18, 2026 agreement to merge Covetrus with MWI Animal Health. Those developments add to the sector’s recent services consolidation, including Rover’s November 2025 close of its acquisition of Australian marketplace Mad Paws. (webdisclosure.com)
The backdrop is a pet industry that's no longer operating in the fast-growth conditions of the pandemic years. Analysts tracking the sector have described a more selective market, with slower economic growth, inflation, and changing ownership patterns reshaping demand. Petfood Industry, citing Cascadia Capital’s Winter 2025/2026 outlook, reported that attractive pet businesses can still command healthy interest and valuations, but buyers have become more disciplined. Another industry report found global pet-sector deal volume fell in Q4 2025 versus Q3, even as pet products remained the most active subsector and veterinary care services still logged deal activity. (petfoodindustry.com)
The latest deals show what buyers want. In food and consumables, AlphaPet is continuing a buy-and-build strategy around local premium brands, positioning Cpro Food as its fifth acquisition since 2020 and another step in expanding its European footprint. In services, Rover has kept building internationally: after Blackstone agreed to acquire Rover in a $2.3 billion transaction announced in November 2023, Rover completed its purchase of Mad Paws in November 2025, extending its reach in Australia while keeping the Mad Paws brand in market. (webdisclosure.com)
For veterinary professionals, the most consequential move is the planned Covetrus-MWI merger. Cencora and Covetrus said the combined company would bring together distribution, pharmacy, and practice management capabilities, with the stated goal of improving operational efficiencies and supporting practice growth. Cencora also said its fiscal 2026 guidance does not assume the deal closes before September 30, 2026, underscoring that the transaction still faces customary closing conditions and regulatory review. AAHA described the proposed merger as a significant shift for the veterinary distribution landscape, which is a fair characterization given both companies’ footprint in clinic purchasing and workflow infrastructure. (covetrus.com)
Industry commentary points to cautious optimism rather than a full-blown deal boom. Pet Food Processing reported that inflation, tariffs, and regulatory shifts slowed pet food M&A through the second half of 2025, even as the sector remained attractive to investors and global pet food sales were expected to keep growing. Petfood Industry separately reported that experts surveyed on 2026 prospects were "cautiously optimistic," and suggested the market may be starting to warm after a sluggish stretch. That lines up with what this winter’s deals suggest: buyers are still active, but they're targeting assets that add scale, geography, premium positioning, or operational leverage. (petfoodprocessing.net)
Why it matters: For veterinary teams, more consolidation upstream can translate into downstream changes in pricing, fulfillment, software integration, and competitive choice. If the Covetrus-MWI deal closes, clinics could see a more unified offering across inventory procurement, pharmacy, and practice systems, which may create efficiencies for some hospitals but also raise questions about supplier concentration. At the same time, continued consolidation in pet food and consumer services reflects a market where pet parents are still spending, but more selectively, and where companies are chasing premium niches, omnichannel reach, and defensible recurring revenue. That can affect referral patterns, client expectations, and the mix of products and services clinics are asked to support. (covetrus.com)
What to watch: The next marker is execution. Veterinary professionals should watch the regulatory path and integration plans for Covetrus-MWI, whether more regional or specialty distributors become targets, and whether 2026 deal activity broadens beyond premium brands and scaled platforms into a wider set of pet health and veterinary service assets. Based on current reporting, the market appears to be reopening, but selectively, with the strongest interest still centered on businesses that can show resilience, margin potential, and strategic fit. (covetrus.com)